Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 15, Issue 19
|
pp. 10133–10145
Sheng-Mai-Yin inhibits doxorubicin-induced ferroptosis and cardiotoxicity through regulation of Hmox1
Back to article
Figure 1
(1 of 7)
−
100%
+
Figure 1.
The HPLC analysis of SMY and its main components, including 5-HMF (1), lobetyolin (2), Schisandrin B (3), schizandrin (4).
(
A
) Standards. (
B
) Samples.
